• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Microbot Medical Inc. - Common Stock (NQ:MBOT)

    2.095 +0.005 (+0.24%)
    Streaming Delayed Price Updated: 10:29 AM EST, Jan 12, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Microbot Medical Inc. - Common Stock

    < Previous 1 2 3 4 5 Next >
    News headline image
    Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System
    Adoption of LIBERTY is Consistent with Emory’s Commitment to the Growing and Evolving Field of Interventional Radiology 
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
    $25.2 million in first closing, $1.2 million in second closing and $2.8 million in third and final closing, with up to an additional approximately $63 million of potential aggregate gross proceeds upon... 
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System
    Livestream Interview Can be Viewed on September 24th at 10:45am ET at Benzinga All Access Live 
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
    $25.2 million in first closing and $4 million in second closing, with up to an additional approximately $63 million of potential aggregate gross proceeds upon the exercise in full of short-term... 
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds
    $25.2 million in first closing and $4 million in second closing, with up to an additional approximately $63 million of potential aggregate gross proceeds upon the exercise in full of short-term... 
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference
    Live Presentation to be Webcast Today at 9am ET 
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    DIH Appoints Scott R. Burell to DIH Holding US, Inc. Board of Directors
    From DIH Holding US, Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities
    Strengthens Balance Sheet and Continues Commercialization Readiness Plans for the LIBERTY® System as it Nears FDA Marketing Clearance Decision 
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales
    Company Continues to Strengthen Organizational Infrastructure with Success-Driven Medical Device Veteran 
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting
    Leading Endovascular Innovators to Highlight Emergence and Growth of Robotics in the Specialty 
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical® Added to the Russell Microcap® Index
    Automatic inclusion in the appropriate growth and value style indexes 
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China
    Significant Development Supports Long-Term Global Commercial Strategy of the LIBERTY® System 
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System
    The addition of the head of Sales Operations & Analytics aims to strengthen sales infrastructure and launch execution 
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Global Robotic Exoskeleton Market Size Expected to Reach $30 Billion By 2032 as A.I. Influence Disrupts the Industry
    EQNX::TICKER_START (NYSE:KULR),(NASDAQ:CHRW),(NYSE:PBI),(NYSE:GXO),(NASDAQ:MBOT) EQNX::TICKER_END 
    Via FinancialNewsMedia
    Topics Artificial Intelligence
    News headline image
    REMINDER: Microbot Medical Announces Data from the Company’s ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting
    Company Reaffirms Expected Timing of FDA Decision With Respect to 510(K) Clearance of LIBERTY® During the Current Second Quarter 
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Global Robotic Exoskeleton Market Size Expected to Reach $30 Billion By 2032 as A.I. Influence Disrupts the Industry
    From FN Media Group LLC
    Via GlobeNewswire
    News headline image
    Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Robotic Telesurgery Data from Collaboration with Corewell Health™ Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting
    Research Collaboration demonstrates the feasibility of using the LIBERTY® Endovascular Robotic System between separate and remote facilities in a coronary simulation model 
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical Closes $13 Million Registered Direct Offering
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
    From Microbot Medical Inc.
    Via GlobeNewswire
    < Previous 1 2 3 4 5 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.